Discontinued — last reported Q1 '20

Collaborative Arrangement With Related Party — Revenue

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2017

Last reportedQ1 2020May 7, 2020

Rolls up toTotal Revenue

How to read this metric

An increase suggests successful execution of joint development milestones or increased commercial activity within the affiliated network, while a decrease may indicate the conclusion of specific collaborative phases or a shift in strategic partnership focus.

Detailed definition

This metric represents revenue recognized from strategic partnerships and collaborative agreements with entities that sh...

Peer comparison

Peers in the biotechnology and pharmaceutical sectors often report similar figures under 'Collaboration Revenue' or 'License and Milestone Revenue,' though the 'related party' designation is specific to companies with complex corporate structures or venture-backed ecosystems.

Metric ID: mrna_segment_collaborative_arrangement_with_related_party_revenues

Similar Metrics at Other Companies

Neurocrine BiosciencesNBIX View metric

Roivant SciencesROIV View metric

IncyteINCY View metric

Roivant SciencesROIV View metric

Natera, Inc.NTRA View metric

PfizerPFE View metric

Frequently Asked Questions

What does collaborative arrangement with related party — revenue mean?: Revenue earned from research and development partnerships with companies that have a close ownership or business relationship with the firm.